Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 September 2008, Vol. 112, No. 6, pp. 2171-2172.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pozner, R.
Right arrow Articles by Schattner, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pozner, R.
Right arrow Articles by Schattner, M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Next Article next article arrow

InsideBlood

CHEMOKINES

Comment on Hitchcock et al, page 2222

TPO signaling: when the tyrosines go marching in(side)

Roberto Pozner, and Mirta Schattner

HEMATOLOGICAL RESEARCH INSTITUTE

In this issue of Blood, Hitchcock and colleagues provide novel insights into the molecular pathways regulating TPO-mediated c-Mpl trafficking, highlighting the essential role of AP2 in receptor internalization and lysosomal degradation as new pieces in the TPO/c-Mpl signaling puzzle.

Thrombopoietin (TPO) and its receptor c-Mpl are the primary regulators of megakaryocytopoiesis and play a critical role in hematopoietic stem cell biology. Upon TPO binding, c-Mpl facilitates tyrosine (Y) phosphorylation of cytoplasmic signaling proteins and activation of several pathways that control cellular proliferation, megakaryocyte development, and survival. Turning off the TPO signal is critical to prevent uncontrolled proliferation; however, the molecular processes governing this process are still not fully elucidated. Suppressors of cytokine signaling (SOCS), phosphatases, and other proteins, such as focal adhesion kinase and members of the Src family kinases (SFKs), have recently emerged as negative modulators of TPO signaling.1,2

Although it is still a matter of debate, soon after the discovery of TPO it was suggested that internalization of TPO/c-Mpl complexes by platelets and megakaryocytes is a primary means of regulating plasma TPO levels. A phosphotyrosine (Y112) and 2 dileucine motifs (L54L55 and I57L58) within the cytoplasmic domain of the receptor have been identified to promote TPO-mediated c-Mpl internalization and proliferative signaling. Furthermore, c-Mpl recycling from intracellular pools has also been demonstrated.3

Clathrin-mediated endocytosis constitutes the major route for selective receptor internalization in higher eukaryotes. Clathrin molecules are recruited to the cell surface where they interact with transmembrane proteins via adaptor proteins (AP) such as AP2 to form clathrin-coated pits. YXX{varphi} and [DE]XXXL[IL] motifs in the cytoplasmic tails of transmembrane pro-teins have been identified as the binding sites for AP2.4

Hitchcock et al, in a series of elegant experiments, have demonstrated that AP2 has a key role in TPO-stimulated clathrin-mediated c-Mpl internalization in both Jak2 and SFKs activation-dependent pathways. Bearing in mind that c-Mpl contains 2 YXX{varphi} motifs in its cytoplasmic domain at Tyr8 (Y8RRL) and Tyr78 (Y78RRL) and using BaF3-Mpl–expressing cells with point mutations at Y8 or Y78, the authors have identified Y78RRL as the binding motif for AP2 in the c-Mpl receptor. Interestingly, they also observed that cells expressing the Y78F mutation exhibited increased proliferation and prolonged activation of Jak2, STAT5, AKT, and ERK1/2 in response to TPO. The observation that knocking down AP2 did not have the same effects on signaling as the mutation led the authors to suggest that Y78 may be responsible not only for the internalization but also for the activation of other signaling pathways that restrain the TPO signal.

Although the clearance of c-Mpl was recently attributed only to the proteasome,5 this study unveiled that lysosomal degradation is another control mechanism of c-Mpl expression and also identifies Y8RRL as the lysosomal targeting motif. Accordingly, Y8F c-Mpl cells showed an increase in c-Mpl recycling to the cell surface (see figure).


Figure 1
View larger version (77K):
[in this window]
[in a new window]

 
Regulation of TPO-mediated c-Mpl receptor internalization and degradation. After TPO binding, clathrin-coated pits are formed through the interaction between the AP2 and Y78RRL motif in the cytoplasmic tail of c-Mpl. The internalization process is regulated by Jak2 as well as SFKs activation (1). Following invagination and budding, (2) clathrin-coated vesicles are routed to endocytic pathways that direct the c-Mpl receptor to recycling and/or degradation (3). While Y78RRL negatively regulates proliferation, Y8RRL targets c-Mpl lysosomal degradation.

 
This paper is the first report that describes the YXX{varphi} motif for receptor internalization and lysosome targeting in the hematopoietic growth factor receptor family and raises many new questions that await an answer. What mechanisms control the balance between c-Mpl degradation/recycling? What contribution does c-Mpl internalization make to the TPO proliferative signal? What would be the biological impact of the c-Mpl Y78 and Y8 mutations in primary cells? To what extent are Y mutations linked to the pathogenesis of myeloproliferative diseases? Investigating these questions should help us to understand the interplay between the actors controlling the TPO/c-Mpl scenario.

Footnotes

Conflict-of-interest disclosure: The authors declare no competing financial interests. {blacksquare}

REFERENCES

  1. Hitchcock IS, Fox NE, Prevost N, et al. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout. Blood. 2008;111:596–604.[Abstract/Free Full Text]

  2. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006;354:2034–2045.[Free Full Text]

  3. Dahlen DD, Broudy VC, Drachman JG. Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs. Blood. 2003;102:102–108.[Abstract/Free Full Text]

  4. Bonifacino JS, Lippincott-Schwartz J. Coat proteins: shaping membrane transport. Nat Rev Mol Cell Biol. 2003;4:409–414.[CrossRef][Medline] [Order article via Infotrieve]

  5. Royer Y, Staerk J, Costuleanu M, et al. Janus kinases affect thrombopoietin receptor cell surface localization and stability. J Biol Chem. 2005;280:27251–27261.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation
Ian S. Hitchcock, Maximus M. Chen, Jennifer R. King, and Kenneth Kaushansky
Blood 2008 112: 2222-2231. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pozner, R.
Right arrow Articles by Schattner, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pozner, R.
Right arrow Articles by Schattner, M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020